Kane Biotech to Release Second Quarter 2024 Financial Results on August 29, 2024 – Conference Call to Follow
August 22, 2024 16:30 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”) will announce its second quarter 2024 financial results after market close on...
Xos, Inc. delivers strong unit delivery, sales growth and promising operating profit performance in the second quarter of 2024
August 13, 2024 16:05 ET
|
Xos, Inc.
Xos today reported financial results for the second quarter ended June 30, 2024
8 Ways To Create a Better Earnings Experience
August 12, 2024 09:00 ET
|
Notified
NEW YORK, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Earnings season is a critical moment for public companies. To enhance investor trust and engagement, it’s important to focus on clear and concise...
Lantronix Enters Into Cooperation Agreement With 180 Degree Capital Corp.
August 12, 2024 07:00 ET
|
Lantronix, Inc.
IRVINE, Calif., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Lantronix Inc. (NASDAQ: LTRX) (the “Company”), a global leader in compute and connectivity IoT solutions, today announced that it has entered into a...
Calian annonce les résultats du troisième trimestre
August 07, 2024 19:00 ET
|
Calian Group Ltd.
(Tous les montants dans le communiqué sont en dollars canadiens.) OTTAWA, Ontario, 07 août 2024 (GLOBE NEWSWIRE) -- CalianMD Group Ltd. (TSX:CGY), une société de produits et services divers...
Calian Reports Results for the Third Quarter
August 07, 2024 19:00 ET
|
Calian Group Ltd.
Calian® Group Ltd. (TSX:CGY), released its results for the third quarter, which ended June 30, 2024.
Astiva Health Launches Investor Relations Website, Reinforcing Commitment to Transparent Communication
August 06, 2024 09:00 ET
|
Astiva Health
ORANGE, Calif., Aug. 06, 2024 (GLOBE NEWSWIRE) -- via IBN - Astiva Health, a leader in innovative and culturally aware healthcare solutions, is pleased to announce the launch of its new Investor...
AC Immune Reports Second Quarter 2024 Financial Results and Provides a Corporate Update
August 06, 2024 07:00 ET
|
AC Immune SA
AC Immune Reports Second Quarter 2024 Financial Results and Provides a Corporate Update Announced exclusive option and license agreement with Takeda for ACI-24.060 on May 13 for $100 million upfront...
Bionano to Present at the Canaccord Genuity 44th Annual Growth Conference
July 31, 2024 16:01 ET
|
Bionano Genomics
SAN DIEGO, July 31, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano’s president and chief executive officer, will present at the...
Lantronix Announces CEO and CFO Featured at Canaccord Genuity’s 44th Annual Growth Conference on Aug. 14, 2024
July 31, 2024 07:00 ET
|
Lantronix, Inc.
IRVINE, Calif., July 31, 2024 (GLOBE NEWSWIRE) -- Lantronix Inc. (NASDAQ: LTRX), a global leader in compute and connectivity IoT solutions, today announced its participation in the 44th Annual...